Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-27 @ 2:43 AM
Study NCT ID:
NCT07042594
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2025-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
Sponsor:
Suzhou Ribo Life Science Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RBFI2101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None